No shortage of TB drugs in India: Govt
New Delhi: The Ministry of Health & Family Welfare has informed that there is no shortage of anti-tuberculosis drugs in the country. There has been regular supply of Anti-TB drugs to all the State/UTs from the central level under the National TB Elimination Programme (NTEP) throughout the year and regular assessments are conducted to evaluate the stock positions at various levels, from central warehouses to peripheral health institutes.
Further, State/UTs have been provisioned with resources for local procurement for limited quantities as and when required to meet the emergent requirements.
The details of stock positions of anti-tuberculosis drugs placed are as under:
|
Stock of Anti TB Drugs as on 06-12-2023 |
||
|
Drug Name |
Total Stock available |
Stocks will last (approx. months) |
|
Tab. 2FDC (P) (H50 & R75) |
18078984 |
More than 6 months |
|
Tab.3FDC CP (A) (H75,R150 & E275) |
159287016 |
For 4 months |
|
Tab 3FDC(P) (H50, R75, Z150) |
17889844 |
More than 6 months |
|
Tab. 4FDC(A) (H75, R150, Z400 & E275) |
94250072 |
For 4 months |
|
Tab. Bedaquiline (BDQ)-L |
9835849 |
More than 6 months |
|
Cap. Clofazimine 100mg |
7901607 |
More than 6 months |
|
Cap. Clofazimine 50mg |
129405 |
More than 6 months |
|
Cap. Cycloserine 250mg |
12591104 |
More than 6 months |
|
Tab. Delamanid 50mg |
3688946 |
More than 6 months |
|
Tab. Ethambutol 100mg |
40895959 |
More than 6 months |
|
Tab. Ethambutol 800mg |
2759910 |
For 3 months |
|
Tab. Ethionamide 250mg |
15096309 |
More than 6 months |
|
Tab. Moxifloxacin 400mg |
25720793 |
More than 6 months |
|
Tab. Isoniazid 300mg |
43951761 |
More than 6 months |
|
Tab. Levofloxacin 250mg |
10770158 |
More than 6 months |
|
Tab. Levofloxacin 500mg |
9862422 |
More than 6 months |
|
Tab Linezolid 600mg |
4190760 |
More than 6 months |
|
Tab. Pyrazinamide 500mg |
6262558 |
More than 6 months |
|
Tab. Pyrazinamide 750mg |
5862684 |
More than 6 months |
|
Tab. Pyridoxine 100mg |
20060750 |
More than 6 months |
Read also: Vague and ill-informed: Centre dismisses claims on shortage of anti-TB drugs in India
